Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin injection for symptoms of diabetic neuropathy
IRCT20240116060710N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2024
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3 trial of neuronox in diabetic neuropathy, sponsored by Shahid Beheshti University of Medical Sciences. Started Feb 2024; status: completed.
02
Drugs
neuronox
03
Conditions
diabetic neuropathy
Beyond the preview
Go deeper on IRCT20240116060710N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240116060710N1.